ARK Invest Reshuffles Biotech, Sells Coinbase & Ginkgo by Lilu Anderson 25.06.2024 Cathie Wood's ARK shifts focus, selling Ginkgo and Coinbase, while investing in 10X Genomics and Roku in a biotech-centered portfolio ...
Breakthrough Vaccine: One Shot Protects Against All Virus Strains by Lilu Anderson 18.04.2024 Researchers have successfully developed a single-dose vaccine that prompts the production of T-cells and "memory" B cells to fight against ...
PDS Biotech Clinical Update and Financial Results by Mark Eisenberg 27.03.2024 Published results show a 36-month survival rate of 20% with immunotherapy. ICI resistant group had a 72% 12-month OS rate. ...
Coya Therapeutics Secures Key Therapy License by Lilu Anderson 13.02.2024 Clinical-stage biotech company Coya Therapeutics expands its IP portfolio with a license for a novel combination therapy using low dose ...
AN2 Therapeutics Pauses Trial: Efficacy Concerns Rise by Mark Eisenberg 12.02.2024 AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...
Researchers from Cleveland Clinic and IBM Unveil AI Strategy for Immunotherapy Targets by Lilu Anderson 23.01.2024 Cleveland Clinic and IBM join forces to advance immunotherapy research through AI, unlocking new targets for cancer therapy. #Immunotherapy #AI ...